Portability of therapeutic effects (letter commenting: J Clin Epidemiol. 2015;68(11):1251--1260.)

False discovery rate control is not always a replacement for Bonferroni adjustment (Letter commenting on: J Clin Epidemiol. 2014;67:850-7).

[1] Cohen JF, Chalumeau M, Cohen R, Korevaar DA, Khoshnood B, Bossuyt PM. Cochran’s Q test was useful to assess heterogeneity in likelihood ratios in studies of diagnostic accuracy. J Clin Epidemiol 2015;68:299e306. [2] Cochran WG. The combination of estimates from different experiments. Biometrics 1954;10:101e29. [3] Cochran WG. Some methods for strengthening the common c tests. Biometrics 195...

J . Clin . Microbiol . Santini

J. Clin. Med

Prostate cancer is a major hormone-dependent tumor affecting men, and is often treated by hormone therapy at the primary stages. Despite its initial efficiency, the disease eventually acquires resistance, resulting in the recurrence of castration-resistant prostate cancer. Recent studies suggest that dysregulation of microRNA (miRNA) function is one of the mechanisms underlying hormone therapy ...

J. Clin. Med

Diabetes Mellitus (DM) is a growing worldwide epidemic. It was estimated that more than 366 million people would be affected. DM has spread its presence over the world due to lifestyle changes, increasing obesity and ethnicities, among others. Diabetic nephropathy (DN) is one of the most important DM complications. A changing concept has been introduced from the classical DN to diabetic chronic...

Am J Clin Nutr